Lisa Page

Partner

Dr Lisa Page is a partner in the IP, IT and commercial team in Birmingham who specialises in the life sciences sector. She acts for companies across the sector including biotechs, pharmaceutical companies, start-ups and spin-outs, as well as laboratory services and contract research organisations.

She advises on all stages of the product development pathway including regulatory advice, pre-clinical and clinical development contracts. Her work includes advising companies, universities and research organisations on multi-party collaborations and licensing transactions including spin-out licensing. Lisa has particular experience in the development stage of new products, covering pipeline, co-development, and licensing. Her regulatory practice includes medical device advice for software and AI as medical products.

I integrate my scientific understanding, life sciences expertise, and legal knowledge to deeply grasp my clients’ technologies and the legal challenges they face. This allows me to secure optimal commercial outcomes, protect their valuable intellectual property, and support their growth and development. Working with such innovative organisations is truly inspiring.

Lisa Page, Partner

More recently, Lisa has focussed on the use and impact of AI in the life sciences sector. This includes software and AI medical devices and clinical trials where clients need advice to assist them in navigating this changing landscape.

Lisa has a scientific PhD and direct practical experience of working in the pharmaceutical industry before re-training as a solicitor. Her scientific background provides a specialist insight into the issues faced by her clients and enables her to speak their language when providing advice. She worked in-house for a number of organisations including at the Energy Technologies Institute and Coventry University. Lisa plays an active role in the life sciences sector, presenting regularly at conferences and events. She is non-executive director of the West Midlands Health Technology Cluster Organization and a trustee for the Roper-Hall Eye Foundation. Lisa is listed as recommended individual for patent transactions in IAM Patent 1000.

Recent work highlights

Precedents for innovative scientific agency

Supporting the Advanced Research and Invention Agency in drafting its precedent grant funding agreements for its projects that ‘reach for the edge of the possible’.

Phase III clinical trial deployment

Assisting SynOx Therapeutics in its launch of a Phase III trial for emactuzumab, its novel antibody treatment for the rare disease tenosynovial giant cell tumour.

Biotech client agreements

Advising and negotiating numerous agreements with CROs and laboratory services providers for a biotech client to support its move into phase 1 clinical trials for its novel patented small molecule.

Patent licence amendment

Advising a client on the commercial and legal terms for the amendment of its exclusive patent licence to grant access to the client’s regulatory data package for a commercial fee from the patent owner.

AI development agreement

Drafting a software development agreement with an AI provider to improve a client’s medical device software and advising on the regulatory requirements for the approval of the client’s medical device software including classification advice.

Commercial licensing agreements

Advising a university spin-out on its patent and know-how licence agreement with the university and subsequent co-development licensing agreement with a commercial entity that intends to utilise this platform technology.

Lab services client support

Advising a laboratory services client on various master services agreements with customers ensuring that it retains the IP in its technologies and methodologies as part of service delivery.

University licensing-out agreements

Drafting and negotiating a series of agreements for a UK university to licence its internationally deployed patented technologies.

Lab services client support

Advising a laboratory services client on various master services agreements with customers ensuring that it retains the IP in its technologies and methodologies as part of service delivery.

University licensing-out agreements

Drafting and negotiating a series of agreements for a UK university to licence its internationally deployed patented technologies.